NDC 0069-8141

Xalkori

Crizotinib

Xalkori is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Crizotinib.

Product ID0069-8141_19c4d302-9bf2-4557-8f22-f2c94341fd1a
NDC0069-8141
Product TypeHuman Prescription Drug
Proprietary NameXalkori
Generic NameCrizotinib
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2011-08-26
Marketing CategoryNDA / NDA
Application NumberNDA202570
Labeler NamePfizer Laboratories Div Pfizer Inc
Substance NameCRIZOTINIB
Active Ingredient Strength200 mg/1
Pharm ClassesKinase Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Receptor Tyrosine Kinase Inhibitors [MoA],Cytochrome P450 2B6 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Organic Cation Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0069-8141-20

60 CAPSULE in 1 BOTTLE (0069-8141-20)
Marketing Start Date2011-08-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0069-8141-20 [00069814120]

Xalkori CAPSULE
Marketing CategoryNDA
Application NumberNDA202570
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-08-26

Drug Details

Active Ingredients

IngredientStrength
CRIZOTINIB200 mg/1

OpenFDA Data

SPL SET ID:2a51b0de-47d6-455e-a94c-d2c737b04ff7
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1148502
  • 1148504
  • 1148506
  • 1148498
  • UPC Code
  • 0300698140201
  • 0300698141208
  • Pharmacological Class

    • Kinase Inhibitor [EPC]
    • Cytochrome P450 3A Inhibitors [MoA]
    • Receptor Tyrosine Kinase Inhibitors [MoA]
    • Cytochrome P450 2B6 Inhibitors [MoA]
    • P-Glycoprotein Inhibitors [MoA]
    • Organic Cation Transporter 1 Inhibitors [MoA]
    • Organic Cation Transporter 2 Inhibitors [MoA]

    NDC Crossover Matching brand name "Xalkori" or generic name "Crizotinib"

    NDCBrand NameGeneric Name
    0069-8140XalkoriCRIZOTINIB
    0069-8141XalkoriCRIZOTINIB

    Trademark Results [Xalkori]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    XALKORI
    XALKORI
    85069606 3967863 Live/Registered
    Pfizer Inc.
    2010-06-23

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.